VRTX
VERTEX PHARMACEUTICALS INC / MA
NASDAQ · Healthcare · Biotechnology · US
$549.04
+3.44%Forward multiples
Based on analyst estimates
- P/E forward
- 28.84x
- P/E 2026E
- 29.47x
- P/E 2027E
- 26.18x
- P/E 2028E
- 21.99x
- P/S forward
- 9.73x
Trailing multiples
Trailing twelve months
- P/E TTM
- 35.06x
- PEG TTM
- 1.60x
- Price / book
- 6.66x
- Price / sales
- 10.72x
- Price / cash flow
- 37.68x
Enterprise value
- Enterprise value
- $139.4B
- EV / sales
- 10.73x
- EV / EBITDA
- 28.06x
- EV / EBIT
- 31.69x
- Market cap
- $139.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026